Josh Siegfried

PHD Doctor of Philosophy,  Mayo Clinic - Rochester 

Location: Germany

Consulting Services

Scientific Writing Research Consulting

Areas Of Interest

Literature, Modern Model, Biologic MA144A1 Periorificial Lentiginosis Syndromes Degeneration, Intervertebral Disc Basal Cell Cancer Atherosclerotic Plaques Preservation, Organ Renshaw Cell CL-13900 Afazol Grin Flocculation Greenland Cost Measure Arthrocentesis,Temporomandibular Joints Hair-Brain Syndrome Complex, Eisenmenger's Congenital Immunodeficiency Diseases Gestagenic Agents Postoperative Residual Weakness Nerve Tissue Myocyte Specific Enhancer Factor 2B Person, Transgendered H 7 Pandalid Shrimps Autosomal Dominant Opitz G Bbb Syndrome Visually Impaired Person Infarct, Hepatic Piedras Cutaneous Allergic Vasculitis Pteris aquilinas Creatures, Legendary Disease, Urological Viridal

Professional Narrative

Dr. Josh Siegfried was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Siegfried has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Amgen 1993
Senior Director, Amgen 2002

Education

Bachelor of science in nursing, Baylor College 1992
Bachelor of science in nursing, Weill Medical College 2014

Referees


Publications

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :